It’s been a busy week in the cannabis world – and at H&W Media headquarters.
This week, we launched our new title, Cannabis Wealth, which will focus on business, investment and policy at an exciting time for the industry.
Cannabis Health will keep doing what it does, bringing you the must-read stories about health and wellness in the cannabis world.
With so much going on – and now with two websites to read – you could be forgiven for missing the odd bit of news.
Well, not to worry, here’s your weekend digest of the most important stories from both of our titles. Have a great weekend.
1. ‘Medical cannabis has more ‘benefits’ and is ‘safer’ than prescription drugs for chronic pain’
New research has backed up patients’ views that medical cannabis helps with long-lasting pain.
According to new research, cannabis-derived treatments improve patients’ quality of life more than any other treatment for chronic pain.
Read the full story here.
2. ‘Dad-of-three says cannabis helped him beat terminal cancer’
After being diagnosed with terminal cancer, Scott Davis started taking cannabis oil. Despite being given 12 to 18 months to live, two-and-a-half years later the tumour has “disappeared”.
In the summer of 2018 at the age of 38, Scott Davis started experiencing stomach cramps and loss of appetite. When he started losing weight without explanation, he decided to visit his doctor.
Read Scott’s story here.
3. ‘Why women in pain are turning to medical cannabis’
Women’s health is routinely looked over in the health system, campaigners say.
The current medical system sees women’s pain routinely dismissed, while complex conditions are often left undiagnosed and untreated for years. Now many are looking for another option.
Find out more about how women are turning to cannabis-based treatments here.
4. ‘Food Standards Agency answers key CBD questions after 48 hours of confusion
The Food Standards Agency has moved to address concerns about the novel foods regulations roll out after 48 hours of confusion in the industry.
Officials working for the regulator are sifting through more than 750 applications made before the March 31 deadline that was set ahead of the imposition of new rules on the sector.
On April 19, the FSA published the first public register of products which have been ‘validated’ and given the green light to remain on UK shelves pending full authorisation – but just 23 products from three firms were included.
We’ve been pressing the regulator for answers – you can read them here.
5. ‘Appalled’: Chanelle McCoy of Pureis CBD pulls no punches on state of industry
One of the first and only businesses so far to get validation is Pureis CBD, which got on early and is reaping the rewards.
Celeb investor Chanelle McCoy, who co-founded the firm, spoke to Cannabis Wealth about a landmark week for her company – and she didn’t mince her words about other CBD firms.
Read the explosive quotes here.
6. ‘Sana Life Science and its mission to unlock the medical cannabis industry’
Arjun Rajyagor and Ben Hamburger had the sort of careers young would-be businesspeople dreamed of, plying their trade at some of the world’s biggest and most prestigious corporate firms.
The trouble is, they hated it – so they quit. Now they’re running a medical cannabis company which is aiming to get the market moving in the UK by winning over clinicians with cold, hard data.
Read their fascinating story here.
- Malta gives green light to three new cannabis clubs
- European Commission must address ‘inequality’ in access to medicinal cannabis across EU
- 1 in 8 older US adults now use cannabis products, finds study
- 3 main contributors to the entourage effect for cannabis consumers to consider
- Medical cannabis doesn’t impair cognitive function – study
- Ukraine’s medical cannabis legalisation delayed by opponents
- News4 months ago
NHS approves major clinical trial on cannabis medicines and chronic pain
- News6 months ago
UK patient secures first NHS reimbursement for cannabis flowers
- Advocacy6 months ago
Inside a UK cannabis club: changing lives, tackling stigma, building community
- News4 months ago
UK research finds GP support for cannabis as an alternative to opioids for chronic pain
- Industry4 months ago
‘Landmark’ ruling gives hope for UK CBD flower businesses
- News4 months ago
Malta: Advocates emphasise positive effects of cannabis reform amid ‘normalisation’ concerns
- Science4 months ago
Five new cannabis studies – ALS, epilepsy, Parkinson’s, chronic pain and blood pressure
- Science6 months ago
New research suggests alcohol, not cannabis, is the real ‘gateway’ drug